At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the ...

Melissa Beson, 37, was last seen on the Lac du Flambeau Reservation on March 17. She is the fifth person to go missing from ...

Merck & Co. is undervalued with strong oncology growth, key R&D investments, and shareholder returns. Click here to read an ...

Element has responded to the lawsuit with a statement saying, “Element is proud of its strong history of innovation. We are ...

Experts explain the science behind Biden's advanced prostate cancer diagnosis, including how common it is and what treatments are available.

Sequencing created clarity about which genes were being ... Avonex, used to treat multiple sclerosis — the excitement following their incorporation spurred the growth of other biotech start ...

Investors now have three ASX-listed stem cell therapy companies to choose from – and we can thank Mesoblast for inspiring the third.

Guardian article mangles language and facts, pulling the wool over the public’s eyes about the real capabilities of GM. By ...

We have a responsibility to ensure that our discoveries are used in the public interest. That isn’t always easy.

Scientists have created what they believe to be the most broadly effective antivenom to date — and its key ingredient came ...

Roughly five months after AstraZeneca scrapped a major investment plan in its home country, the United Kingdom has found a ...

For decades, scientists and surgeons around the world have been trying to solve the organ donor crisis. The answer could be ...